一般研究认为急性心肌梗塞心肺复苏是溶栓治疗的禁忌症，它可能存在致命性出血情况，因此对心肺复苏后采用溶栓治疗没有得到广泛性认同，当前临床研究也只是少数在心肺复苏后进行溶栓治疗，多数情况下是肺栓塞相关。从临床研究看，多数出血等并发症是因为长期溶栓治疗的原因（>24 h），高剂量短期进行溶栓治疗出血概率很小。%The general study cardiopulmonary resuscitation (CPR) of acute myocardial infarction are contraindications to thrombolysis treatment, it may be fatal bleeding, after cardiopulmonary resuscitation (CPR) for thrombolysis therapy has not been extensive recognition, from the current clinical research is only a few thrombolysis therapy after cardiopulmonary resuscitation (CPR), in most cases is related to pulmonary embolism. From the research, most of the complications such as bleeding because thrombolysis treatment for a long time (>24 hours), high dose of short-term thrombolysis treatment of bleeding probability is very small.
展开▼
